029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
FVL801外生殖器恶性肿瘤组织芯片,附病理分级、TNM和临床分期,39例/78点
点 数78例 数39
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:FVL801
 
外生殖器恶性肿瘤组织微阵列芯片,包含鳞状细胞癌29例,恶性黑色素瘤7例,癌旁皮肤组织6例(其中3例与鳞状细胞癌匹配),一例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Vul
-Vulva
Per
-Perineum
 
AT (*)
 
Malignant (*)
 
Malignant (I)
 
Malignant (IB)
 
Malignant (II)
TISSUE  ARRAYS FVL801
1
2
3
4
5
6
7
8
9
10
A
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
B
VUL
VUL
PER
PER
VUL
VUL
VUL
VUL
VUL
VUL
C
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
D
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
E
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
F
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
G
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
H
VUL
VUL
VUL
VUL
VUL
VUL
VUL
VUL
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1129FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
A2229FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
A3356FVulvaSquamous cell carcinoma1T1bN0M0IBMalignantN
A4456FVulvaSquamous cell carcinoma1T1bN0M0IBMalignantN
A5548FVulvaSquamous cell carcinoma1**MalignantN
A6648FVulvaSquamous cell carcinoma1**MalignantN
A7753FVulvaSquamous cell carcinoma1**MalignantN
A8853FVulvaSquamous cell carcinoma1**MalignantN
A9966FVulvaSquamous cell carcinoma1**MalignantN
A101066FVulvaSquamous cell carcinoma1**MalignantN
B11159FVulvaSquamous cell carcinoma1T1bN0M0IBMalignantN
B21259FVulvaSquamous cell carcinoma1T1bN0M0IBMalignantN
B31351MPerineumSquamous cell carcinoma1**MalignantN
B41451MPerineumSquamous cell carcinoma1**MalignantN
B51546FVulvaSquamous cell carcinoma1**MalignantN
B61646FVulvaSquamous cell carcinoma1**MalignantN
B71756FVulvaSquamous cell carcinoma1**MalignantN
B81856FVulvaSquamous cell carcinoma1**MalignantN
B91982FVulvaSquamous cell carcinoma1**MalignantN
B102082FVulvaSquamous cell carcinoma1**MalignantN
C12162FVulvaSquamous cell carcinoma1**MalignantN
C22262FVulvaSquamous cell carcinoma1**MalignantN
C32359FVulvaSquamous cell carcinoma2**MalignantN
C42459FVulvaSquamous cell carcinoma2**MalignantN
C52557FVulvaMalignant melanoma***MalignantN
C62657FVulvaMalignant melanoma***MalignantN
C72760FVulvaSquamous cell carcinoma2**MalignantN
C82860FVulvaSquamous cell carcinoma2**MalignantN
C92948FVulvaSquamous cell carcinoma1**MalignantN
C103048FVulvaSquamous cell carcinoma1**MalignantN
D13185FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
D23285FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
D33346FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
D43446FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
D53580FVulvaSquamous cell carcinoma1**MalignantN
D63680FVulvaSquamous cell carcinoma1**MalignantN
D73740FVulvaSquamous cell carcinoma1**MalignantN
D83840FVulvaSquamous cell carcinoma1**MalignantN
D93988FVulvaSquamous cell carcinoma1**MalignantN
D104088FVulvaSquamous cell carcinoma1**MalignantN
E14138FVulvaSquamous cell carcinoma1**MalignantN
E24238FVulvaSquamous cell carcinoma1**MalignantN
E34358FVulvaSquamous cell carcinoma2T2N0M0IIMalignantN
E44458FVulvaSquamous cell carcinoma2T2N0M0IIMalignantN
E54549FVulvaSquamous cell carcinoma1T1N0M0IMalignantN
E64649FVulvaSquamous cell carcinoma1T1N0M0IMalignantN
E74743FVulvaSquamous cell carcinoma1**MalignantN
E84843FVulvaSquamous cell carcinoma1**MalignantN
E94970FVulvaSquamous cell carcinoma1T1N0M0IMalignantN
E105070FVulvaSquamous cell carcinoma1T1N0M0IMalignantN
F15142FVulvaSquamous cell carcinoma2T2N0M0IIMalignantN
F25242FVulvaSquamous cell carcinoma2T2N0M0IIMalignantN
F35350FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
F45450FVulvaSquamous cell carcinoma1T2N0M0IIMalignantN
F55578FVulvaSquamous cell carcinoma3**MalignantN
F65678FVulvaSquamous cell carcinoma3**MalignantN
F75742FVulvaSquamous cell carcinoma2T2N0M0IIMalignantN
F85842FVulvaSquamous cell carcinoma2T2N0M0IIMalignantN
F95972FVulvaSquamous cell carcinoma1**MalignantN
F106072FVulvaSquamous cell carcinoma1**MalignantN
G16142FVulvaMalignant melanoma***MalignantN
G26242FVulvaMalignant melanoma***MalignantN
G36326FVulvaMalignant melanoma***MalignantN
G46426FVulvaMalignant melanoma***MalignantN
G56545FVulvaMalignant melanoma***MalignantN
G66645FVulvaMalignant melanoma***MalignantN
G76772FVulvaMalignant melanoma***MalignantN
G86872FVulvaMalignant melanoma***MalignantN
G96915FVulvaMalignant melanoma***MalignantN
G107015FVulvaMalignant melanoma***MalignantN
H17129FVulvaSquamous cell carcinoma2**MalignantN
H27256FVulvaCancer adjacent skin tissue of No.3/4***ATN
H37348FVulvaCancer adjacent skin tissue of No.5/6***ATN
H47453FVulvaCancer adjacent skin tissue of No.7/8***ATN
H57548FVulvaCancer adjacent skin tissue***ATN
H67635FVulvaCancer adjacent skin tissue***ATN
H77740FVulvaCancer adjacent skin tissue***ATN
H87848FVulvaCancer adjacent skin tissue***ATN
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情